Health Evolution Partners
VC Fund
San Francisco, United States
Health Evolution Partners is a VC fund in San Francisco focused on Chemical and Software. Health Evolution Partners invests in rapidly growing companies in the health care industry. We target opportunities across the key sectors of the health care economy – hospitals, physicians, managed care, pharmaceutical developers, device makers and consumer products and services. Our investments are led by an exceptional team of health careinvestment professionals and seasoned operators. We believe that the firm’s extensive network of health care specialists, policymakers and thought leaders give our companies a significant competitive advantage. By partnering with talented management teams, we are able to create long-term value and in turn, drive attractive returns for our investors.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
- Fund size:
- $700M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Health Evolution Partners invests in
Stages Health Evolution Partners invests in
Countries Health Evolution Partners invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Braden Kelley
|
|||
|
Christopher D. McFadden
|
|||
David Brailer
|
|||
Investment Focus
Industry
- Chemical 1 (33%)
- Software 1 (33%)
- Nutrition 1 (33%)
- Health Care 1 (33%)
- Life Science 1 (33%)
Stage
- Series A 1 (33%)
- Funding Round 1 (33%)
- Venture - Series Unknown 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Braden Kelley
Partner
|
Partner | Total investments: 0 | Find email | |
|
Christopher D. McFadden
Managing Partner
|
Managing Partner | Total investments: 0 | Find email | |
|
David Brailer
Managing Partner , CEO & Chairman
|
Managing Partner , CEO & Chairman | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Prolacta Bioscience
|
Prolacta Bioscience, Inc. (www.prolacta.com) is a life science company founded by serial entrepreneur, Elena Medo who has dedicated her career to improving quality of life for sick infants by Advancing the Science of Human MilkTM. Prolacta creates specialty formulations made exclusively from human milk for the nutritional needs of critically ill,premature infants in neonatal intensive care units. It is the first and only company to provide a human milk fortifier made from 100% human milk, Prolact+ H2MF. They operate a pharmaceutical grade processing plant and have designed and patented processes that enable them to make their one-of-a-kind life saving products. Prolacta is committed to making a meaningful difference in the lives of the most vulnerable infants through world-class research and innovative products. | $35M / Venture - Series Unknown / Dec 06, 2016 | |
CambridgeSoft
|
CambridgeSoft Corporation is a leading supplier of discovery, collaboration, and knowledge enterprise solutions, desktop software, scientific databases and consulting services to the pharmaceutical, biotechnology, and chemical industries. The Company provides:Enterprise solutions, desktop software, scientific databases, and professionalservices for biotechnology, drug discovery and chemical research, including software, databases, and web sites which enable customers to create, analyze and communicate chemical, biological, and scientific information more effectively.CambridgeSoft's products are used primarily in the pharmaceutical, biotechnology and chemical industries, as well as in higher education and in academic and government research. The company's principal software offering, Chem & Bio Office, which includes Chem & Bio Draw, is the de facto standard and primary communication tool on the chemist's desktop. Chem & Bio Office Enterprise, an enterprise implementation of Chem & Bio Office desktop, enables research information organizations to deploy application and information solutions using Internet, intranet, and extranet technologies | $31.3M / Nov 17, 2009 | |
Foundation Radiology
|
Foundation Radiology is a state of the art diagnostic imaging professional services company offering both on-site radiology and teleradiology solutions for hospital institutions and outpatient imaging centers on a 7 x 24 x 365 basis. | $10M / Series A / Apr 13, 2009 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Health Evolution Partners invest in?
Health Evolution Partners invests primarily in Chemical, Software and Nutrition startups, most often at Series A and Funding Round stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Health Evolution Partners?
Public channels for Health Evolution Partners include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Health Evolution Partners?
The team at Health Evolution Partners includes Braden Kelley (Partner), Christopher D. McFadden (Managing Partner) and David Brailer (Managing Partner , CEO & Chairman). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
